261 related articles for article (PubMed ID: 22844733)
1. [Biological markers in the diagnosis of dementia and Alzheimer's disease].
Meiner Z; Rosenmann H
Harefuah; 2012 May; 151(5):289-93, 318. PubMed ID: 22844733
[TBL] [Abstract][Full Text] [Related]
2. MRI and CSF studies in the early diagnosis of Alzheimer's disease.
de Leon MJ; DeSanti S; Zinkowski R; Mehta PD; Pratico D; Segal S; Clark C; Kerkman D; DeBernardis J; Li J; Lair L; Reisberg B; Tsui W; Rusinek H
J Intern Med; 2004 Sep; 256(3):205-23. PubMed ID: 15324364
[TBL] [Abstract][Full Text] [Related]
3. Magnetic resonance and PET studies in the early diagnosis of Alzheimer's disease.
Mosconi L; De Santi S; Rusinek H; Convit A; de Leon MJ
Expert Rev Neurother; 2004 Sep; 4(5):831-49. PubMed ID: 15853510
[TBL] [Abstract][Full Text] [Related]
4. Assessment of cerebrospinal fluid (CSF) beta-amyloid (1-42), phosphorylated tau (ptau-181) and total Tau protein in patients with Alzheimer's disease (AD) and other dementia at Siriraj Hospital, Thailand.
Thaweepoksomboon J; Senanarong V; Poungvarin N; Chakorn T; Siwasariyanon N; Washirutmangkur L; Udompunthuruk S
J Med Assoc Thai; 2011 Feb; 94 Suppl 1():S77-83. PubMed ID: 21721431
[TBL] [Abstract][Full Text] [Related]
5. Cerebrospinal fluid biomarker results in relation to neuropathological dementia diagnoses.
Brunnström H; Rawshani N; Zetterberg H; Blennow K; Minthon L; Passant U; Englund E
Alzheimers Dement; 2010 Mar; 6(2):104-9. PubMed ID: 20298970
[TBL] [Abstract][Full Text] [Related]
6. Meta-analysis of CSF and MRI biomarkers for detecting preclinical Alzheimer's disease.
Schmand B; Huizenga HM; van Gool WA
Psychol Med; 2010 Jan; 40(1):135-45. PubMed ID: 19863841
[TBL] [Abstract][Full Text] [Related]
7. Addressing population aging and Alzheimer's disease through the Australian imaging biomarkers and lifestyle study: collaboration with the Alzheimer's Disease Neuroimaging Initiative.
Ellis KA; Rowe CC; Villemagne VL; Martins RN; Masters CL; Salvado O; Szoeke C; Ames D;
Alzheimers Dement; 2010 May; 6(3):291-6. PubMed ID: 20451879
[TBL] [Abstract][Full Text] [Related]
8. [Use of CSF biomarkers in the diagnostics of memory diseases].
Remes A; Leikola M; Majamaa K; Nikkanen M; Ruokonen LI; Rusanen M; Tapiola T; Ylikotila P; Vallittu AM; Pirttilä T
Duodecim; 2009; 125(20):2215-22. PubMed ID: 19998760
[TBL] [Abstract][Full Text] [Related]
9. [Biomarkers in spinal fluid of patients with dementia].
Skogseth RE; Fladby T; Mulugeta E; Aarsland D
Tidsskr Nor Laegeforen; 2011 Nov; 131(22):2235-8. PubMed ID: 22085948
[TBL] [Abstract][Full Text] [Related]
10. [Role of biomarkers in the early diagnosis of Alzheimer's disease].
Molinuevo Guix JL
Rev Esp Geriatr Gerontol; 2011 Oct; 46 Suppl 1():39-41. PubMed ID: 22152914
[TBL] [Abstract][Full Text] [Related]
11. [Cerebral blood flow and cerebral oxygen metabolism in patients with dementia of frontal lobe type].
Kitamura S; Araki T; Sakamoto S; Iio M; Terashi A
Rinsho Shinkeigaku; 1990 Nov; 30(11):1171-5. PubMed ID: 2085920
[TBL] [Abstract][Full Text] [Related]
12. Alzheimer's disease.
Scheltens P; Blennow K; Breteler MM; de Strooper B; Frisoni GB; Salloway S; Van der Flier WM
Lancet; 2016 Jul; 388(10043):505-17. PubMed ID: 26921134
[TBL] [Abstract][Full Text] [Related]
13. What the study of persons at risk for familial Alzheimer's disease can tell us about the earliest stages of the disorder: a review.
Ringman JM
J Geriatr Psychiatry Neurol; 2005 Dec; 18(4):228-33. PubMed ID: 16306245
[TBL] [Abstract][Full Text] [Related]
14. Measurement of thirteen biological markers in CSF of patients with Alzheimer's disease and other dementias.
Blasko I; Lederer W; Oberbauer H; Walch T; Kemmler G; Hinterhuber H; Marksteiner J; Humpel C
Dement Geriatr Cogn Disord; 2006; 21(1):9-15. PubMed ID: 16244482
[TBL] [Abstract][Full Text] [Related]
15. [Biomarker of dementia: clinical and preclinical diagnosis].
Shoji M
Nihon Rinsho; 2012 May; 70(5):857-63. PubMed ID: 22620013
[TBL] [Abstract][Full Text] [Related]
16. Alzheimer's disease in late-life dementia: a minor toxic consequence of devastating cerebrovascular dysfunction.
Henry-Feugeas MC
Med Hypotheses; 2008; 70(4):866-75. PubMed ID: 17825499
[TBL] [Abstract][Full Text] [Related]
17. Blood pressure, white matter lesions and medial temporal lobe atrophy: closing the gap between vascular pathology and Alzheimer's disease?
Korf ES; Scheltens P; Barkhof F; de Leeuw FE
Dement Geriatr Cogn Disord; 2005; 20(6):331-7. PubMed ID: 16179827
[TBL] [Abstract][Full Text] [Related]
18. Novel ventriculo-peritoneal shunt in Alzheimer's disease cerebrospinal fluid biomarkers.
Silverberg GD; Mayo M; Saul T; Carvalho J; McGuire D
Expert Rev Neurother; 2004 Jan; 4(1):97-107. PubMed ID: 15853620
[TBL] [Abstract][Full Text] [Related]
19. [Image analysis in patients with dementia].
Tamaki N
Hokkaido Igaku Zasshi; 1996 May; 71(3):303-7. PubMed ID: 8752524
[TBL] [Abstract][Full Text] [Related]
20. Neuroimaging in dementias.
de Souza LC; Lehéricy S; Dubois B; Stella F; Sarazin M
Curr Opin Psychiatry; 2012 Nov; 25(6):473-9. PubMed ID: 23037962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
